ITP is diagnosed primarily by a complete blood count and a blood smear [18] and is managed by corticosteroids and intravenous immunoglobulins (IVIG) in most instances followed by second line therapies, including thrombopoietin receptor agonist (TPO-RA), rituximab, or splenectomy amongst non-responders or corticosteroids dependent [33], [19]. Here, MPL is linked to autoimmune thrombocytopenic purpura.